Cargando…

In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics

Achromobacter spp. lung infection in cystic fibrosis has been associated with inflammation, increased frequency of exacerbations, and decline of respiratory function. We aimed to evaluate in vivo the inflammatory effects of clinical isolates exhibiting different pathogenic characteristics. Eight cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandri, Angela, Saitta, Giulia Maria, Veschetti, Laura, Boschi, Federico, Passarelli Mantovani, Rebeca, Carelli, Maria, Melotti, Paola, Signoretto, Caterina, Boaretti, Marzia, Malerba, Giovanni, Lleò, Maria M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139000/ https://www.ncbi.nlm.nih.gov/pubmed/37108596 http://dx.doi.org/10.3390/ijms24087432

Ejemplares similares

Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance
por: Sandri, Angela, et al.
Publicado: (2022)

Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection
por: Sandri, Angela, et al.
Publicado: (2021)

Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
por: Veschetti, Laura, et al.
Publicado: (2021)

Toothbrushes may convey bacteria to the cystic fibrosis lower airways
por: Passarelli Mantovani, Rebeca, et al.
Publicado: (2019)

Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients
por: Veschetti, Laura, et al.
Publicado: (2021)

Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis
por: Passarelli Mantovani, Rebeca, et al.
Publicado: (2020)

Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
por: Veschetti, Laura, et al.
Publicado: (2020)

Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice
por: Sandri, Angela, et al.
Publicado: (2018)

Achromobacter spp. genetic adaptation in cystic fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Resistome, Mobilome and Virulome Analysis of Shewanella algae and Vibrio spp. Strains Isolated in Italian Aquaculture Centers
por: Zago, Vanessa, et al.
Publicado: (2020)

Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy
por: Sandri, Angela, et al.
Publicado: (2023)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Detecting Carbapenemases in Animal and Food Samples by Droplet Digital PCR
por: Carelli, Maria, et al.
Publicado: (2022)

Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
por: Chalhoub, Hussein, et al.
Publicado: (2022)

Duplex real-time PCR assay for the simultaneous detection of Achromobacter xylosoxidans and Achromobacter spp.
por: Price, Erin P., et al.
Publicado: (2020)

Genetic Adaptation of Achromobacter sp. during Persistence in the Lungs of Cystic Fibrosis Patients
por: Ridderberg, Winnie, et al.
Publicado: (2015)

Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts
por: Cremonini, Eleonora, et al.
Publicado: (2016)

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
por: Lambiase, A., et al.
Publicado: (2011)

The Emerging Nosocomial Pathogen Klebsiella michiganensis: Genetic Analysis of a KPC-3 Producing Strain Isolated from Venus Clam
por: Simoni, Serena, et al.
Publicado: (2022)

Exoproducts of the Most Common Achromobacter Species in Cystic Fibrosis Evoke Similar Inflammatory Responses In Vitro
por: Sahl, Cecilia, et al.
Publicado: (2023)

VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
por: Neuwirth, Catherine, et al.
Publicado: (2006)

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
por: Firmida, M.C., et al.
Publicado: (2016)

Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
por: Firmida, Mônica Cássia, et al.
Publicado: (2017)

Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis
por: Tetart, Macha, et al.
Publicado: (2019)

Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease
por: Stobbelaar, Kim, et al.
Publicado: (2016)

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature
por: Cools, Piet, et al.
Publicado: (2016)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis
por: Le Goff, Mélanie, et al.
Publicado: (2022)

1066. In Vitro and in Vivo Antimicrobial Activity of Cefiderocol and Comparators against Achromobacter spp
por: Nakai, Ryuichiro, et al.
Publicado: (2021)

Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304
por: Jeukens, Julie, et al.
Publicado: (2015)

Complete Genome Sequence of Achromobacter xylosoxidans MN001, a Cystic Fibrosis Airway Isolate
por: Badalamenti, Jonathan P., et al.
Publicado: (2015)

Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients
por: Rodrigues, Elenice RA, et al.
Publicado: (2016)

Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes
por: Nielsen, Signe M., et al.
Publicado: (2016)

730. Cefiderocol for the Treatment of Achromobacter xylosoxidans Infections in Two Lung Transplant Patients with Cystic Fibrosis
por: Warner, Nathaniel C, et al.
Publicado: (2019)

Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis
por: Khademi, S. M. Hossein, et al.
Publicado: (2021)

Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung
por: Menetrey, Quentin, et al.
Publicado: (2021)

Achromobacter spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients
por: Crone, Cornelia Geisler, et al.
Publicado: (2022)

Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains
por: Trancassini, Maria, et al.
Publicado: (2014)

First IncHI2 Plasmid Carrying mcr-9.1, bla(VIM-1), and Double Copies of bla(KPC-3) in a Multidrug-Resistant Escherichia coli Human Isolate
por: Simoni, Serena, et al.
Publicado: (2021)

UV-A Radiation: Safe Human Exposure and Antibacterial Activity
por: Sandri, Angela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d1ms0l0s0jj7fp8gfvnf9v8qks